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and disease progression. Host factors can typically be divided into
three categories (Chatterjee, 2010): 1) genes encoding cell-surface re-
ceptors or ligands for these proteins, including the classic CCR5 32-bp
deletion; 2) geneswithin the human leukocyte antigens (HLA) that reg-
ulate host responses to infection; and 3) other cytokine and immune re-
sponse genes, including the homozygosity at position−308 in the TNF-
alpha promoter. More recently genome-wide association studies
(GWAS) have detected new genetic factors associatedwith HIV-1 infec-
tion (van Manen et al., 2012). In addition, an extensive array of host
physiological responses have been assessed, including MCP-1 (CCL2)
(Price et al., 2007).
In relation to HIV-1 susceptibility, the co-receptors CXCR4 and CCR5
are classically linked to infection of T cells and cells of the monocyte–
macrophage lineage (MML), respectively. CCR5-utilizing viruses are
the major type of virus transmitted therefore MML cells have been
thought to contribute to early disease progression. More recently it
has been demonstrated that T lymphocytes may also be a major vehicle
for HIV-1 transmission. Transmitted viruses preferentially use CCR5 as a
co-receptor, require high levels of CD4, and are able to replicate efﬁ-
ciently in primary CD4+ T-cells, suggesting a CCR5-utilizing T-tropic
viral phenotype (Ochsenbauer et al., 2012). Subsequently, these foun-
der viruses can infect MML cells, resulting in the development of a
wider target cell population that expresses higher levels of CCR5 than
T cells (Ochsenbauer et al., 2012). Although in the classical sense, co-
receptor utilization remains themost important factor in HIV-1 suscep-
tibility, a number of other host factors are currently under investigation
that also appear to play a role in cellular susceptibility. Often these host
factors interact with viral proteins thereby affecting the efﬁciency of
viral infection.
HIV-1 viral protein R (Vpr) is a multifunctional virion-associated ac-
cessory protein (Cohen et al., 1990). Vpr functions both early after entry
into cells and also following integration of the proviral genome
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ulating the expression of immediate-early HIV-1 genes from the now
integrated proviral genome. This mechanism is utilized prior to the
transition to Tat-driven gene expression. Vpr is critical in the viral repli-
cation cycle in non-dividing cells, such as monocytes (Connor et al.,
1995), whereas it has been shown to be dispensable in T-lymphocytes
(Eckstein et al., 2001).
In themanuscript by Chiang et al. within this issue of EBioMedicine, a
new host factor is described as playing a role in HIV-1 susceptibility
(Chiang et al., 2014). This host factor, MRJ-L, is the large splice isoform
of DNAJB6 (a homolog of heat shock protein 40) and the authors state
that it has been shown to interact with Vpr, however this data, to date
has not been published and therefore this point is in need of further de-
tailed exploration. The authors, studying cohorts of “men who had sex
with men” (MSM), found that macrophage expression of MRJ-L varied
among healthy subjects but was signiﬁcantly and substantially higher
in HIV-1-infected subjects. ThemacrophageMRJ-L expression level pre-
dicted the risk of HIV-1 infection with similar power as whether or not
subjects engaged in unprotected sexual contact. To demonstrate a
cause-and-effect relationship betweenMRJ-L expression andHIV-1 sus-
ceptibility, monocytes from healthy subjects were isolated and then dif-
ferentiated and infected ex vivo. Interestingly, this experiment revealed
thatmacrophageswith highMRJ-L expressionweremore susceptible to
HIV-1 infection than those with low MRJ-L expression. Furthermore,
RNAi knockdown of MRJ-L in high-expressing cells decreased suscepti-
bility to infection, while lentiviral over-expression of MRJ-L in low-
expressing cells increased their susceptibility to infection. These results
clearly implicate high expression of MRJ-L with macrophage suscepti-
bility to HIV infection. The authors were able to identify a plausible
mechanism, showing that MRJ-L colocalizes with Vpr and is required
for localizing Vpr to the nucleus. Although the localization experiments
were performed in HeLa cells, because of the importance of Vpr in mac-
rophages, the extension can be made that MRJ-L plays a major role in
the nuclear transport of this important viral protein (and possibly the
whole pre-integration complex) in other cell types. The stochastic ex-
pression of MRJ-L in uninfected subjects raises the possibility that ge-
netic factors controlling this variability are also responsible for
variability in susceptibility to infection.
Numerous studies have demonstrated the role of host proteins in
HIV-1 susceptibility, and the strong evidence provided by Chiang et al.
thatMRJ-L levels impact susceptibility to infectionmakes it an attractiveense (http://creativecommons.org/licenses/by/3.0/).
100 V. Pirrone et al. / EBioMedicine 1 (2014) 99–100therapeutic target. However, caution needs to be taken with regard to
developing a therapy to reduce MRJ-L expression. Studies have shown
a link between decreased levels of MRJ-L and malignancies such as
breast cancer, with MRJ-L being shown to regulate several key players
in tumor formation and metastasis, and demonstrating its ability to
functionally retard tumor growth (Mitra et al., 2008). More complete
studies are needed to determine the role of MRJ-L in macrophages, as
well as more directed therapeutic targeting to speciﬁc cells to avoid po-
tentially devastating off-target consequences.Conﬂicts of Interest
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